arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

Bon Natural Life Ltd

BON
$1.10 ▼ -0.01 (-0.90%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
7 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bon Natural Life Ltd faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.0M
Dividend Yield —
Revenue Growth -21.7% ↘
Op. Margin -8.7% ↘
ROIC -3.3% ↘
FCF / Share $0.05 ↗
Trailing P/E —
Price / Book 0.1x
FCF Yield 4.4%
Debt / Equity 0.21
info Valuation on last close. End-of-day price, Nov 3, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$18.67M
↓ -21.7% —
Net Income Profit after all expenses
$-1.99M
↓ -601.0% —
Operating Margin Operating profit as % of sales
-8.7%
↓ -210.6% 16th
FCF / Share Free cash flow per share
$0.05
↑ +101.5% —
Long-Term Debt Long-term obligations
$1.92M
↑ +34.4% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
20
Returns
40
Financial Health ↑
54
Cash Quality
20

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 6 quarters